We are live on ! Find out more
USPH icon

US Physical Therapy

257 hedge funds and large institutions have $1.31B invested in US Physical Therapy in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 99 increasing their positions, 83 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 18

19% more repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 83

6% more funds holding

Funds holding: 242257 (+15)

1.76% more ownership

Funds ownership: 100.6%102.36% (+1.8%)

7% less capital invested

Capital invested by funds: $1.4B → $1.31B (-$95.2M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

86% less call options, than puts

Call options by funds: $67K | Put options by funds: $491K

Holders
257
Holders Change
+15
Holders Change %
+6.2%
% of All Funds
3.69%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
34
Increased
99
Reduced
83
Closed
18
Calls
$67K
Puts
$491K
Net Calls
-$424K
Net Calls Change
-$90K
Name Holding Trade Value Shares
Change
Change in
Stake
COPPSERS
176
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$273K -$2.13K -24 -0.7%
TFS
177
Thoroughbred Financial Services
Tennessee
$269K +$51.6K +582 +22%
Susquehanna International Group
178
Susquehanna International Group
Pennsylvania
$267K +$9.05K +102 +3%
BHCM
179
Brevan Howard Capital Management
Jersey
$266K +$279K +3,144 New
ProShare Advisors
180
ProShare Advisors
Maryland
$264K +$73.5K +828 +36%
Handelsbanken Fonder
181
Handelsbanken Fonder
Sweden
$254K +$53.2K +600 +25%
Wealth Enhancement Advisory Services
182
Wealth Enhancement Advisory Services
Minnesota
$252K -$8.16K -92 -3%
Creative Planning
183
Creative Planning
Kansas
$252K +$264K +2,975 New
PAS
184
Park Avenue Securities
New York
$251K -$13K -147 -5%
PWS
185
Precision Wealth Strategies
Missouri
$239K +$12.2K +137 +5%
JFG
186
Jefferies Financial Group
New York
$234K +$245K +2,761 New
TRCT
187
Tower Research Capital (TRC)
New York
$233K -$62.3K -702 -20%
PS
188
Principal Securities
Iowa
$223K +$53.3K +601 +29%
Zurich Cantonal Bank
189
Zurich Cantonal Bank
Switzerland
$223K +$84.8K +956 +57%
AWAU
190
Alliance Wealth Advisors (Utah)
Utah
$218K -$9.23K -104 -4%
CCIA
191
Campbell & Co Investment Adviser
Maryland
$218K -$524K -5,904 -70%
QC
192
Quadrature Capital
United Kingdom
$212K -$212K -2,388 -49%
SMAM
193
Sugar Maple Asset Management
Wisconsin
$212K +$222K +2,500 New
Amundi
194
Amundi
France
$206K +$18.5K +208 +9%
SG Americas Securities
195
SG Americas Securities
New York
$205K -$310K -3,496 -59%
CIBC Private Wealth Group
196
CIBC Private Wealth Group
Georgia
$198K -$2.48K -28 -1%
FHA
197
First Horizon Advisors
Tennessee
$126K +$26.4K +298 +25%
AIP
198
Ameritas Investment Partners
Nebraska
$124K
Fifth Third Bancorp
199
Fifth Third Bancorp
Ohio
$96K -$17.6K -198 -15%
VI
200
Vestcor Inc
New Brunswick, Canada
$94K

USPH Hedge Fund Activity: Q3 2024 in Review

257 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in US Physical Therapy (USPH) for Q3 2024, worth a combined $1.31B — down 6.8% from $1.4B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new USPH positions and 18 closed out — a net gain of 16 holders — while 99 added to existing stakes and 83 trimmed.

The largest buyer was State Street, adding an estimated $8.81M. The largest seller was Barclays, cutting an estimated $28.1M.

  • 257 institutional investors held US Physical Therapy (USPH) as of Q3 2024, up from 242 in Q2 2024.
  • Funds reported $1.31B of US Physical Therapy stock for Q3 2024, down 6.8% quarter-over-quarter.
  • 34 funds opened new US Physical Therapy positions in Q3 2024 and 18 closed out, a net change of +16 holders.
  • The largest US Physical Therapy buyer in Q3 2024 was State Street, an estimated $8.81M added.
  • The largest US Physical Therapy seller in Q3 2024 was Barclays, an estimated $28.1M sold.

Based on aggregated 13F filings for Q3 2024.